Session Details

Session Details

03:45 PM - 05:30 PM - Room 318-323

Maksim Mamonkin - PhD - Baylor College of Medicine

Co-Chair

03:45 PM - 05:30 PM - Room 318-323

Eric Smith - MD, PhD - Dana Farber Cancer Institute

Co-Chair

03:45 PM - 04:00 PM - Room 318-323

Sharada Mokkapati - Ph.D - The UT MD Anderson Cancer Center

226: Interferon Alpha Gene Therapy Alters Tumor Metabolism in Bladder Cancer

04:00 PM - 04:15 PM - Room 318-323

Unmesha Thanekar - Master of Science - St. Jude Children's Research Hospital

227: Targeting AML with Naturally Occurring CD7 Negative T Cells Expressing CD7 CAR

04:15 PM - 04:30 PM - Room 318-323

Yining Zhu - Johns Hopkins University

228: A mRNA Lipid Nanoparticle Incorporated Nanofiber-Hydrogel Composite Generates a Local Immunostimulatory Niche for Cancer Immunotherapy

04:30 PM - 04:45 PM - Room 318-323

Ekene Ogbodo - PhD - Mayo Clinic

229: Targeting EphA3 on Glioblastoma Stem Cells with CART Cell Therapy to Overcome GBM Recurrence

04:45 PM - 05:00 PM - Room 318-323

Richard Vile - PhD - Mayo Clinic

230: Combining the Anti-Viral and Anti-Tumor CD8+ T Cell Response Facilitates Immune Checkpoint Blockade Therapy and Oncolytic Virotherapy

05:00 PM - 05:15 PM - Room 318-323

Stephen Kaminksy - Weill Cornell Medical College

231: Adenovirus Capsid-Based Anti-Fentanyl Vaccine Protects Against Fentanyl-Induced Cardio-Respiratory Depression

05:15 PM - 05:30 PM - Room 318-323

Jacob Du - UCSF

232: The Novel Autologous AML Vaccine, TriLeukeVax, Stimulates Robust Anti-Leukemic Patient T Cell Responses